Regulatory Approvals

FDA Clears IND for RiboX’s RXIM002, Circular RNA CAR-T for ITP

By

Regulatory Approvals — FDA Clears IND for RiboX’s RXIM002, Circular RNA CAR-T for ITP  The Clinical Trial Vanguard

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 9, 2026.

By

Related Post

Regulatory Approvals

Yemen attacks Houthis, Turkey’s Kurdish peace bill wins approval, and other Middle East news – Austin American

Regulatory Approvals

FDA Approves First mRNA Flu Vaccine

Regulatory Approvals

FDA Approves mRNA-Based Flu Vaccine

Financial News For All

Business Economy Finance

Commodities Price Update: Crude Oil $78.18, Brent $83.55, Copper $6.59, Coal $104.75 — Aug 9, 2026 8:00 AM EDT

Product Recalls

Louisville Ladder Recalls Over One Million Attic Stairway Ladders Due to Risk of Serious Injury or Death from Fall Hazard

Product Recalls

DR Power Equipment Recalls Lawn Mowers Due to Risk of Serious Injury or Death from Laceration Hazard; Violate Mandatory Standard for Lawn Mowers

Litigation

Regional: Tractor Supply Company Subsidiary Agrees To $5.1 Million Consumer Protection Settlement